Inmune Bio (INMB) Return on Sales (2021 - 2025)
Historic Return on Sales for Inmune Bio (INMB) over the last 5 years, with Q3 2025 value amounting to 1027.52%.
- Inmune Bio's Return on Sales fell 383100.0% to 1027.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 1027.52%, marking a year-over-year decrease of 383100.0%. This contributed to the annual value of 3045.36% for FY2024, which is 28517600.0% down from last year.
- As of Q3 2025, Inmune Bio's Return on Sales stood at 1027.52%, which was down 383100.0% from 1124.58% recorded in Q2 2025.
- In the past 5 years, Inmune Bio's Return on Sales ranged from a high of 39.74% in Q1 2022 and a low of 3045.36% during Q4 2024
- In the last 5 years, Inmune Bio's Return on Sales had a median value of 399.25% in 2022 and averaged 716.19%.
- As far as peak fluctuations go, Inmune Bio's Return on Sales surged by 23762500bps in 2022, and later plummeted by -27461100bps in 2024.
- Over the past 5 years, Inmune Bio's Return on Sales (Quarter) stood at 55.4% in 2021, then decreased by -5bps to 58.16% in 2022, then plummeted by -414bps to 299.25% in 2023, then crashed by -918bps to 3045.36% in 2024, then surged by 66bps to 1027.52% in 2025.
- Its Return on Sales was 1027.52% in Q3 2025, compared to 1124.58% in Q2 2025 and 198.1% in Q1 2025.